Checkpoint inhibitor therapies can be thought of as the molecular “brake release” for the immune system. These drugs eliminate the
Day: June 22, 2024
Pie in the face? Why inflicting mild pain on others pays off
Oh, the joy of inflicting pain upon others. The Germans have a word for it: schadenfreude, meaning “malicious pleasure.” And
Unlocking the entrepreneurial brain: New perspectives on cognitive flexibility
In a recent study led by the University of Liège researchers delved into the intersection of the fields of entrepreneurship
How to make aging a ‘fairer game’ for all wormkind
Why do some people live for longer than others? The genes in our DNA sequence are important, helping avoid disease
Activating molecular target reverses multiple hallmarks of aging
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific
Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementia
Research led by in part by The University of Texas Health Science Center at San Antonio (UT Health San Antonio)
Resiliency shaped by activity in the gut microbiome and brain
A new UCLA Health study has found that resilient people exhibit neural activity in the brain regions associated with improved
Hidden DNA mechanisms of rare genetic diseases uncovered
Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance
Cooling ‘blood oranges’ could make them even healthier — a bonus for consumers
An orange teeming with antioxidants and other health benefits may be a shot in the arm for consumers and citrus
Lab-grown muscles reveal mysteries of rare muscle diseases
Biomedical engineers at Duke University have developed a new technique to better understand and test treatments for a group of